How CRISPR-Cas9 Contributed to Rare Disease Research in 2021
Brydie Thomas-Moore, PhD
Research from this past year highlights the potential of CRISPR-Cas9 technology in modeling and treating rare disease
Articles by Brydie Thomas-Moore, PhD
Reducing the Variability of Exome Sequencing
Brydie Thomas-Moore, PhD
A look at interlaboratory variability of exome testing and ways labs can reduce this variability to improve patient care
Solving Rare Disease Mysteries with Genomics
Brydie Thomas-Moore, PhD
The Solve-RD consortium is striving to improve rare disease diagnostics using genomics
New Technologies Reduce Variability in Breast Cancer Subtyping
Brydie Thomas-Moore, PhD
Emerging technologies in breast cancer diagnostics aim to improve the accuracy of breast cancer subtyping
Strategies to Enhance the Quality of Automated Drug Screening Systems
Brydie Thomas-Moore, PhD
With throughput no longer the major limiting factor in drug screening, focus now lies on how to improve quality